Top 10 Companies in the 1,2‑Ethanedisulfonic Acid Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

MARKET INSIGHTS

Global 1,2‑Ethanedisulfonic acid market size was valued at USD 28.4 million in 2025. The segment is projected to rise to USD 46.5 million by 2034, reflecting a 5.1 % CAGR over the forecast period.

1,2‑Ethanedisulfonic acid, also known as ethionic acid, is a diprotic strong acid containing two sulfonic groups attached to an ethylene backbone. Its high solubility in water and polar solvents, coupled with thermal stability, makes it a valuable reagent in pharmaceutical salt formation, specialty chemical synthesis, and electrochemical processes.

Demand growth is anchored by the pharmaceutical sector’s need to enhance solubility, stability, and bioavailability of active pharmaceutical ingredients (APIs) through salt formation. Expanding applications in organic synthesis and increasing investments in specialty chemical research further reinforce the upward trend. Key producers include established fine chemical manufacturers across Europe and Asia‑Pacific, with Germany and China serving as prominent production hubs.

1,2‑Ethanedisulfonic Acid Market – View in Detailed Research Report

---

Top 10 Companies in the 1,2‑Ethanedisulfonic Acid Market

1. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Broad portfolio of sulfonic acids and specialty chemicals.

BASF’s expertise in sulfonation chemistry and large‑scale production facilities enable consistent supply of high‑purity 1,2‑ethanedisulfonic acid to pharmaceutical and specialty chemical customers.

Sustainability Initiatives: Investment in green chemistry processes and waste reduction across its production lines.

• Continuous improvement of energy efficiency in manufacturing units.
• Development of low‑VOC formulations for specialty acids.
• Collaboration with academic partners on sustainable sulfonation pathways.

2. Lanxess AG

Headquarters: Cologne, Germany
Key Offering: Specialty chemicals for pharmaceuticals, coatings, and adhesives.

Lanxess leverages its advanced catalytic processes to produce high‑purity 1,2‑ethanedisulfonic acid with minimal by‑products, supporting stringent GMP requirements.

Growth Initiatives: Expansion of its specialty acid portfolio in emerging markets.

• Strategic acquisitions of niche chemical producers.
• Enhanced R&D in catalyst development for sulfonic acid synthesis.
• Targeted market penetration in Asia‑Pacific.

3. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: Fine chemicals and laboratory reagents.

TCI’s global distribution network serves both research and industrial customers, providing reliable access to high‑purity 1,2‑ethanedisulfonic acid.

Innovation Focus: Development of advanced reagents for pharmaceutical synthesis.

• Launch of new reagent grades with ultra‑high purity.
• Partnerships with pharmaceutical firms for custom salt formation.
• Digital supply chain solutions for traceability.

4. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: Laboratory reagents and fine chemicals.

Sigma‑Aldrich supplies a wide range of high‑purity acids, including 1,2‑ethanedisulfonic acid, supporting academic and industrial research worldwide.

Research Collaboration: Active participation in joint projects with universities.

• Open‑access reagent catalogues for academia.
• Support for green chemistry initiatives.
• Real‑time analytics for batch traceability.

5. Alfa Aesar (Thermo Fisher Scientific)

Headquarters: Albany, United States
Key Offering: Specialty chemicals for research and industrial use.

Alfa Aesar provides high‑purity 1,2‑ethanedisulfonic acid to research laboratories and pharmaceutical manufacturers, emphasizing consistent quality and compliance.

Quality Focus: Robust quality control and GMP alignment.

• Certified purity specifications for pharmaceutical use.
• Comprehensive batch documentation.
• Dedicated technical support for formulation chemists.

6. Acros Organics (Thermo Fisher Scientific)

Headquarters: Houston, United States
Key Offering: Specialty reagents for analytical chemistry.

Acros Organics delivers high‑purity acids, including 1,2‑ethanedisulfonic acid, to analytical labs and research institutions.

Innovation: Development of reagent kits for advanced analytical methods.

• Integration of analytical data in product catalogues.
• Support for high‑throughput screening.
• Rapid delivery for time‑critical research projects.

7. Sinopharm Chemical Reagent Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Fine chemicals and laboratory reagents.

Sinopharm supplies high‑purity 1,2‑ethanedisulfonic acid to Chinese and regional customers, supporting local pharmaceutical manufacturing.

Regional Strategy: Focus on domestic pharmaceutical and specialty chemical markets.

• Expansion of production capacity to meet rising demand.
• Strengthening quality assurance systems.
• Collaborations with local universities.

8. Wacker Chemie AG

Headquarters: Munich, Germany
Key Offering: Advanced polymeric and specialty chemicals.

Wacker’s expertise in polymer chemistry complements its production of specialty acids, including 1,2‑ethanedisulfonic acid, for advanced material applications.

Research Focus: Development of ion‑exchange materials.

• Investments in polymer functionalization.
• Collaborations with material science institutes.
• Integration of acid intermediates in polymer synthesis.

9. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Pharmaceutical intermediates and laboratory reagents.

Merck supplies high‑purity 1,2‑ethanedisulfonic acid for pharmaceutical development and research, ensuring compliance with regulatory standards.

Quality Assurance: Rigorous GMP compliance and analytical testing.

• Comprehensive batch traceability.
• Dedicated support for formulation chemists.
• Continuous improvement of purification processes.

10. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: Pharmaceutical development and specialty chemicals.

Bayer’s chemical division produces high‑purity acids, including 1,2‑ethanedisulfonic acid, for its global R&D and manufacturing operations.

Innovation Pipeline: Integration of specialty acids in new drug candidates.

• Collaborations with academic partners on novel formulations.
• Investment in green chemistry initiatives.
• Focus on scalable synthesis routes.

---

Download FREE Sample Report: 1,2‑Ethanedisulfonic Acid Market – View in Detailed Research Report

Get Full Report: 1,2‑Ethanedisulfonic Acid Market – View in Detailed Research Report

---

Outlook

The 1,2‑Ethanedisulfonic acid market is poised to benefit from continued expansion of the global pharmaceutical pipeline, particularly in small‑molecule drug development. Regulatory emphasis on salt‑form equivalence in generic drug approvals is likely to sustain demand for high‑purity edisylate salts. Simultaneously, the growth of specialty chemical research and electrochemical applications will open incremental channels, especially in regions investing heavily in advanced manufacturing and green chemistry.

Future Trends

• Emerging drug delivery platforms such as amorphous solid dispersions and nanosuspensions will increase the need for versatile salt‑forming agents.
• Digitalization of supply chains and real‑time quality monitoring will streamline procurement and reduce lead times.
• Increased focus on sustainability will drive the development of low‑VOC and recyclable sulfonic acid intermediates.
• Cross‑industry collaborations between pharmaceutical and materials science sectors will expand the application scope of 1,2‑ethanedisulfonic acid beyond traditional boundaries.